Trevi Therapeutics, Inc. · NASDAQ:TRVI

New Enterprise Associates 16, L.P. reported a 11.60% stake in Trevi Therapeutics, Inc. (Schedule 13D/A)

Event Aug 7, 2025 · Filed Feb 13, 2026

New Enterprise Associates 16, L.P. reported a 11.60% stake in Trevi Therapeutics, Inc., 15,074,080 shares, with active intent on Aug 7, 2025. Filed Feb 13, 2026 (Schedule 13D/A).

Stake
11.60%
Shares
15,074,080
Intent
Active
What changed
Stake changed
Filed together
13 holders

The filing in full

HolderStakeShares
New Enterprise Associates 16, L.P.11.60%15,074,080
NEA Partners 16, L.P.11.60%15,074,080
NEA 16 GP, LLC11.60%15,074,080
NEA 18 Venture Growth Equity, L.P.11.60%15,074,080
NEA Partners 18 VGE, L.P.11.60%15,074,080
NEA 18 VGE GP, LLC11.60%15,074,080
Forest Baskett10.90%14,125,132
Ali Behbahani11.60%15,074,080
Carmen Chang11.60%15,074,080
Anthony A. Florence, Jr.11.60%15,074,080
Mohamad H. Makhzoumi11.60%15,074,080
Scott D. Sandell11.60%15,074,080
Paul Walker11.60%15,074,080

Source

View original at SEC

Related